Cardiovascular Surgical Department, University Hospital of Zurich, Zurich, Switzerland.
Cardiovascular Surgical Department, University Hospital of Zurich, Zurich, Switzerland; Cardiology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health University, Cardiothoracic Department, Spedali Civili, Brescia, Italy.
JACC Cardiovasc Imaging. 2019 Apr;12(4):605-621. doi: 10.1016/j.jcmg.2018.11.034.
Interest in tricuspid valve pathology has rapidly expanded in response to reported poor clinical outcome for functional tricuspid regurgitation and the limited indications and options for treatment. In the past few years, different transcatheter technologies have emerged as alternatives to conventional surgery to serve this untreated high-risk population. In this review, the authors explore the indications for intervention in tricuspid regurgitation according to current guidelines, the published research to support the expansion of these indications including the role of transcatheter interventions, and the risk factors for therapy failure, which may help define the appropriate patient population for treatment.
近年来,各种经导管技术作为传统手术的替代方法应运而生,以满足这一未经治疗的高危人群的需求。在这篇综述中,作者根据当前指南探讨了三尖瓣反流介入治疗的适应证,以及支持扩大这些适应证的已发表研究,包括经导管介入的作用,以及治疗失败的风险因素,这可能有助于确定适合治疗的患者人群。